Journal
ADVANCED MATERIALS
Volume 31, Issue 21, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.201808325
Keywords
cancer treatment; glucose oxidase; starvation therapy; synergistic therapy
Categories
Funding
- National Natural Science Foundation of China [21807074, 51802202, 51573096, 31771036, 51703132]
- Postdoctoral Science Foundation of China [2018M633123, 2017M612727]
- Guangdong Province Natural Science Foundation of Ph.D. Start-up Fund [2018A030310574, 2018A030310566]
- Guangdong Province Natural Science Foundation of Major Basic Research and Cultivation Project [2018B030308003]
- Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [161032]
- Basic Research Program of Shenzhen [JCYJ20170412111100742]
- National Postdoctoral Program for Innovative Talents [BX201600111]
Ask authors/readers for more resources
Over the past 3 years, glucose oxidase (GOx) has aroused great research interest in the context of cancer treatment due to its inherent biocompatibility and biodegradability, and its unique catalytic properties against beta-d-glucose. GOx can effectively catalyze the oxidation of glucose into gluconic acid and hydrogen peroxide. This process depletes oxygen levels, resulting in elevated acidity, hypoxia, and oxidative stress in the tumor microenvironment. All of these changes can be readily harnessed to develop a multimodal synergistic cancer therapy by combining GOx with other therapeutic approaches. Herein, the representative studies of GOx-instructed multimodal synergistic cancer therapy are introduced, and their synergistic mechanisms are discussed systematically. The current challenges and future prospects to advance the development of GOx-based nanomedicines in this cutting-edge research area are highlighted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available